Sarah Shigdar

School of Medicine, Deakin University

Research Area

Biography

Sarah Shigdar has not added Biography.
If you are Sarah Shigdar and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 6	2022

Other Publications

Article	Year
Functional interaction between mutations in the granulocyte colony-stimulating factor receptor in severe congenital neutropenia. British journal of haematology\| PubMed ID: 18513286	2008
Cytochemical characterisation of the leucocytes and thrombocytes from Murray cod (Maccullochella peelii peelii, Mitchell). Fish & shellfish immunology\| PubMed ID: 19332132	2009
RNA aptamer against a cancer stem cell marker epithelial cell adhesion molecule. Cancer science\| PubMed ID: 21281402	2011
Clinical applications of aptamers and nucleic acid therapeutics in haematological malignancies. British journal of haematology\| PubMed ID: 21810089	2011
Cancer stem cell targeting: the next generation of cancer therapy and molecular imaging. Therapeutic delivery\| PubMed ID: 22834199	2012
Enhanced antitumor efficacy and reduced systemic toxicity of sulfatide-containing nanoliposomal doxorubicin in a xenograft model of colorectal cancer. PloS one\| PubMed ID: 23145140	2012
RNA aptamers targeting cancer stem cell marker CD133. Cancer letters\| PubMed ID: 23196060	2013
The use of sensitive chemical antibodies for diagnosis: detection of low levels of EpCAM in breast cancer. PloS one\| PubMed ID: 23460885	2013
Inflammation and cancer stem cells. Cancer letters\| PubMed ID: 23941828	2014
Aptamers as theranostic agents: modifications, serum stability and functionalisation. Sensors (Basel, Switzerland)\| PubMed ID: 24152925	2013
Inhibition of A/Human/Hubei/3/2005 (H3N2) influenza virus infection by silver nanoparticles in vitro and in vivo. International journal of nanomedicine\| PubMed ID: 24204140	2013
Cancer stem cells: A contentious hypothesis now moving forward. Cancer letters\| PubMed ID: 24333726	2014
Epithelial cell adhesion molecule aptamer functionalized PLGA-lecithin-curcumin-PEG nanoparticles for targeted drug delivery to human colorectal adenocarcinoma cells. International journal of nanomedicine\| PubMed ID: 24591829	2014
Improved efficacy and reduced toxicity of doxorubicin encapsulated in sulfatide-containing nanoliposome in a glioma model. PloS one\| PubMed ID: 25072631	2014
Nucleic acid aptamer-guided cancer therapeutics and diagnostics: the next generation of cancer medicine. Theranostics\| PubMed ID: 25553096	2015
Fabrication of high specificity hollow mesoporous silica nanoparticles assisted by Eudragit for targeted drug delivery. Journal of colloid and interface science\| PubMed ID: 25617610	2015
Superior Performance of Aptamer in Tumor Penetration over Antibody: Implication of Aptamer-Based Theranostics in Solid Tumors. Theranostics\| PubMed ID: 26199647	2015
Overcoming acquired drug resistance in colorectal cancer cells by targeted delivery of 5-FU with EGF grafted hollow mesoporous silica nanoparticles. Nanoscale\| PubMed ID: 26242620	2015
Cancer stem cell targeted therapy: progress amid controversies. Oncotarget\| PubMed ID: 26496035	2015
Application of Aptamers in Histopathology. Methods in molecular biology (Clifton, N.J.)\| PubMed ID: 26552827	2016
EpCAM Aptamer-mediated Survivin Silencing Sensitized Cancer Stem Cells to Doxorubicin in a Breast Cancer Model. Theranostics\| PubMed ID: 26681989	2015
The Application of Aptamers for Immunohistochemistry. Nucleic acid therapeutics\| PubMed ID: 26862683	2016
Challenges and opportunities for siRNA-based cancer treatment. Cancer letters\| PubMed ID: 27045474	2017
Tailored Mesoporous Silica Nanoparticles for Controlled Drug Delivery: Platform Fabrication, Targeted Delivery, and Computational Design and Analysis. Mini reviews in medicinal chemistry\| PubMed ID: 27145854	2018
Truncation and Mutation of a Transferrin Receptor Aptamer Enhances Binding Affinity. Nucleic acid therapeutics\| PubMed ID: 27500826	2016
Development of a Bifunctional Aptamer Targeting the Transferrin Receptor and Epithelial Cell Adhesion Molecule (EpCAM) for the Treatment of Brain Cancer Metastases. ACS chemical neuroscience\| PubMed ID: 28010059	2017
What potential do aptamers hold in therapeutic delivery? Therapeutic delivery\| PubMed ID: 28088878	2017
Aptamer-mediated survivin RNAi enables 5-fluorouracil to eliminate colorectal cancer stem cells. Scientific reports\| PubMed ID: 28724889	2017
Transforming doxorubicin into a cancer stem cell killer via EpCAM aptamer-mediated delivery. Theranostics\| PubMed ID: 29158811	2017
Development of Cell-Specific Aptamers: Recent Advances and Insight into the Selection Procedures. Molecules (Basel, Switzerland)\| PubMed ID: 29186905	2017
Aptamers and Glioblastoma: Their Potential Use for Imaging and Therapeutic Applications. International journal of molecular sciences\| PubMed ID: 29189740	2017
Aptamers as potential therapeutic agents for ovarian cancer. Biochimie\| PubMed ID: 29224849	2018
EpCAM Immunotherapy versus Specific Targeted Delivery of Drugs. Cancers\| PubMed ID: 29329202	2018
Radiolabelled Aptamers for Theranostic Treatment of Cancer. Pharmaceuticals (Basel, Switzerland)\| PubMed ID: 30586898	2018
Aptamer-Based Diagnostics and Therapeutics. Pharmaceuticals (Basel, Switzerland)\| PubMed ID: 30609700	2019
Anything You Can Do, I Can Do Better: Can Aptamers Replace Antibodies in Clinical Diagnostic Applications? Molecules (Basel, Switzerland)\| PubMed ID: 31801185	2019
Bifunctional Aptamer-Doxorubicin Conjugate Crosses the Blood-Brain Barrier and Selectively Delivers Its Payload to EpCAM-Positive Tumor Cells. Nucleic acid therapeutics\| PubMed ID: 32027209	2020
Antibodies, Nanobodies, or Aptamers-Which Is Best for Deciphering the Proteomes of Non-Model Species? International journal of molecular sciences\| PubMed ID: 32260091	2020
The control of epidermal growth factor grafted on mesoporous silica nanoparticles for targeted delivery. Journal of materials chemistry. B\| PubMed ID: 32262664	2015
Mathematical approaches in estimating aptamer-target binding affinity. Analytical biochemistry\| PubMed ID: 32315616	2020
Strategies to bioengineer aptamer-driven nanovehicles as exceptional molecular tools for targeted therapeutics: A review. Journal of controlled release : official journal of the Controlled Release Society\| PubMed ID: 32380206	2020
Non-Invasive Delivery of Therapeutics into the Brain: The Potential of Aptamers for Targeted Delivery. Biomedicines\| PubMed ID: 32422973	2020
Author Correction: Aptamer-mediated survivin RNAi enables 5-fluorouracil to eliminate colorectal cancer stem cells. Scientific reports\| PubMed ID: 33311517	2020
Novel Detection of Nasty Bugs, Prevention Is Better than Cure. International journal of molecular sciences\| PubMed ID: 33375709	2020
Aptamers: Cutting edge of cancer therapies. Molecular therapy : the journal of the American Society of Gene Therapy\| PubMed ID: 34146729	2021
Diagnostics and Therapeutics in Targeting HER2 Breast Cancer: A Novel Approach. International journal of molecular sciences\| PubMed ID: 34200484	2021
Future of PD-1/PD-L1 axis modulation for the treatment of triple-negative breast cancer. Pharmacological research\| PubMed ID: 34861397	2022
Profiling Cancer Cells by Cell-SELEX: Use of Aptamers for Discovery of Actionable Biomarkers and Therapeutic Applications Thereof. Pharmaceutics\| PubMed ID: 35056924	2021
Triple-negative breast cancer brain metastasis: An update on druggable targets, current clinical trials, and future treatment options. Drug discovery today\| PubMed ID: 35101641	2022
Modelling of mass transport and distribution of aptamer in blood-brain barrier for tumour therapy and cancer treatment. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V\| PubMed ID: 35283304	2022